FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912156549> ?p ?o ?g. }

• W2912156549 endingPage "319" @default.
• W2912156549 startingPage "309" @default.
• W2912156549 abstract "Marsdenia tenacissima (Roxb.) Wight et Arn is a vine distributed in southwest area of China and used in folk medicine for treatment of tumors. Recent decades of studies on this plant reveal its synergistic effects with certain anticancer drugs in cancer therapy. In our previous study, an extract ETA which contains total aglycones made from M. tenacissima significantly enhanced antitumor activity of paclitaxel in tumor-bearing mice. However, the effective constituents in ETA and the underlying mechanisms remain unclear.Reveal the active components in ETA as well as the molecular mechanism in enhancing antitumor efficacy of paclitaxel.Main constituents in ETA were purified by chemical methods. Effects of the purified constituents on metabolic activity of CYP450 enzymes were evaluated in human liver microsomes. Ability of the constituents to enhance antitumor activity of paclitaxel were investigated in nude mice bearing HeLa tumors. Pharmacokinetic study was performed in SD rats. Molecular docking was carried out for investigation of drug-protein interactions.Three main C21 steroidal aglycones, 11α-O-tigloyl-12β-O-acetyl-tenacigenin B (MT1), 11α-O-2-methylbutanoyl-12β-O-tigloyl-tenacigenin B (MT2) and 11α-O-2-methylbutanoyl-12β-O-acetyl-tenacigenin B (MT3), together with tenacigenin B (MT4) was prepared from ETA. Among them, MT1, MT2 and MT3 strongly inhibit the metabolic activity of CYP3A4. MT2 also showed inhibitory effects on CYP2C8, CYP2B6 and CYP2C19. In HeLa tumor xenografts, MT1, MT2 and MT3 (30 mg/kg) did not affect tumor growth themselves, but significantly enhanced paclitaxel-induced growth inhibition. In addition, coadministration of MT2 with paclitaxel resulted in significant reduction of liver CYP2C8. In pharmacokinetic study, MT2 significantly increased the blood concentration of paclitaxel with increased AUC value by 2.2-5.3 folds. Molecular docking analysis suggested hydrophobic interaction modes of tenacigenin B derivatives with CYP3A4, and also the essential roles of the C-11 and C-12 ester groups for effective interaction with CYP3A4.Our study proves that, 11α-O-tigloyl-12β-O-acetyl-tenacigenin B, 11α-O-2-methylbutanoyl-12β-O-tigloyl-tenacigenin B and 11α-O-2-methylbutanoyl-12β-O-acetyl-tenacigenin B, which are the main constituents of ETA, are active inhibitors of CYP3A4 with potential to increase therapeutic efficacy of anticancer drugs that are substrates of CYP3A4. Tenacigenin B derivatives with C-11 and C-12 ester group substitutions, or at least a large part of them, are active components in ETA and M. tenacissima to enhance in vivo antitumor efficacies of paclitaxel." @default.
• W2912156549 created "2019-02-21" @default.
• W2912156549 creator A5005042481 @default.
• W2912156549 creator A5011960028 @default.
• W2912156549 creator A5020830818 @default.
• W2912156549 creator A5035438635 @default.
• W2912156549 creator A5051413205 @default.
• W2912156549 creator A5058219030 @default.
• W2912156549 creator A5068191272 @default.
• W2912156549 creator A5073815918 @default.
• W2912156549 creator A5088919704 @default.
• W2912156549 date "2019-05-01" @default.
• W2912156549 modified "2023-10-10" @default.
• W2912156549 title "Tenacigenin B ester derivatives from Marsdenia tenacissima actively inhibited CYP3A4 and enhanced in vivo antitumor activity of paclitaxel" @default.
• W2912156549 cites W1227234993 @default.
• W2912156549 cites W1544994607 @default.
• W2912156549 cites W1849903145 @default.
• W2912156549 cites W1967170065 @default.
• W2912156549 cites W1969583688 @default.
• W2912156549 cites W1972313101 @default.
• W2912156549 cites W1972891658 @default.
• W2912156549 cites W1976580747 @default.
• W2912156549 cites W1996516925 @default.
• W2912156549 cites W2010427019 @default.
• W2912156549 cites W2017242750 @default.
• W2912156549 cites W2018184667 @default.
• W2912156549 cites W2031866272 @default.
• W2912156549 cites W2037534358 @default.
• W2912156549 cites W2058481772 @default.
• W2912156549 cites W2062116016 @default.
• W2912156549 cites W2085957795 @default.
• W2912156549 cites W2118569711 @default.
• W2912156549 cites W2120217572 @default.
• W2912156549 cites W2121960436 @default.
• W2912156549 cites W2153538952 @default.
• W2912156549 cites W2159388020 @default.
• W2912156549 cites W2300655815 @default.
• W2912156549 cites W2325823117 @default.
• W2912156549 cites W2356868318 @default.
• W2912156549 cites W2530326807 @default.
• W2912156549 cites W2536844038 @default.
• W2912156549 cites W2551495885 @default.
• W2912156549 cites W2582033747 @default.
• W2912156549 cites W2592340073 @default.
• W2912156549 cites W2617514955 @default.
• W2912156549 cites W2765783316 @default.
• W2912156549 cites W2801012336 @default.
• W2912156549 cites W2894373686 @default.
• W2912156549 doi "https://doi.org/10.1016/j.jep.2019.02.028" @default.
• W2912156549 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30772481" @default.
• W2912156549 hasPublicationYear "2019" @default.
• W2912156549 type Work @default.
• W2912156549 sameAs 2912156549 @default.
• W2912156549 citedByCount "13" @default.
• W2912156549 countsByYear W29121565492020 @default.
• W2912156549 countsByYear W29121565492021 @default.
• W2912156549 countsByYear W29121565492022 @default.
• W2912156549 countsByYear W29121565492023 @default.
• W2912156549 crossrefType "journal-article" @default.
• W2912156549 hasAuthorship W2912156549A5005042481 @default.
• W2912156549 hasAuthorship W2912156549A5011960028 @default.
• W2912156549 hasAuthorship W2912156549A5020830818 @default.
• W2912156549 hasAuthorship W2912156549A5035438635 @default.
• W2912156549 hasAuthorship W2912156549A5051413205 @default.
• W2912156549 hasAuthorship W2912156549A5058219030 @default.
• W2912156549 hasAuthorship W2912156549A5068191272 @default.
• W2912156549 hasAuthorship W2912156549A5073815918 @default.
• W2912156549 hasAuthorship W2912156549A5088919704 @default.
• W2912156549 hasConcept C109650736 @default.
• W2912156549 hasConcept C112705442 @default.
• W2912156549 hasConcept C121608353 @default.
• W2912156549 hasConcept C126322002 @default.
• W2912156549 hasConcept C150903083 @default.
• W2912156549 hasConcept C181199279 @default.
• W2912156549 hasConcept C185592680 @default.
• W2912156549 hasConcept C202751555 @default.
• W2912156549 hasConcept C207001950 @default.
• W2912156549 hasConcept C2777292972 @default.
• W2912156549 hasConcept C2777366897 @default.
• W2912156549 hasConcept C2777752497 @default.
• W2912156549 hasConcept C526171541 @default.
• W2912156549 hasConcept C55493867 @default.
• W2912156549 hasConcept C71924100 @default.
• W2912156549 hasConcept C86803240 @default.
• W2912156549 hasConcept C98274493 @default.
• W2912156549 hasConceptScore W2912156549C109650736 @default.
• W2912156549 hasConceptScore W2912156549C112705442 @default.
• W2912156549 hasConceptScore W2912156549C121608353 @default.
• W2912156549 hasConceptScore W2912156549C126322002 @default.
• W2912156549 hasConceptScore W2912156549C150903083 @default.
• W2912156549 hasConceptScore W2912156549C181199279 @default.
• W2912156549 hasConceptScore W2912156549C185592680 @default.
• W2912156549 hasConceptScore W2912156549C202751555 @default.
• W2912156549 hasConceptScore W2912156549C207001950 @default.
• W2912156549 hasConceptScore W2912156549C2777292972 @default.
• W2912156549 hasConceptScore W2912156549C2777366897 @default.
• W2912156549 hasConceptScore W2912156549C2777752497 @default.
• W2912156549 hasConceptScore W2912156549C526171541 @default.

• next